<DOC>
	<DOCNO>NCT00002538</DOCNO>
	<brief_summary>RATIONALE : Laparoscopic staging may help doctor plan effective treatment ovarian , primary fallopian tube , primary abdominal cancer . PURPOSE : Phase II trial study effectiveness laparoscopic stag patient ovarian , primary fallopian tube , primary abdominal cancer undergo complete staging .</brief_summary>
	<brief_title>Laparoscopic Staging Patients With Ovarian , Fallopian Tube , Other Primary Abdominal Cancers</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility laparoscopic stag patient incompletely stag ovarian , primary fallopian tube , primary peritoneal cancer . II . Assess adverse effect associate technique . OUTLINE : Surgery . Laparoscopy cytologic examination lymph node sample follow , feasible , surgical resection . PROJECTED ACCRUAL : Up 50 patient accrue approximately 2 year . If 4 evaluable patient complete surgery , study close .</detailed_description>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One follow incompletely stag malignancy : Ovarian cancer cell type Primary fallopian tube carcinoma Primary peritoneal carcinoma No clinical evidence metastasis abdominal organ , adnexa , retroperitoneal lymph node CT contrast prior abdominal surgery No metastases chest xray No contraindication laparoscopy , i.e . : No bowel obstruction No ileus No peritonitis No excessive obesity indicate Quetelet Index 35 ( weight kg/height sqm ) No diaphragmatic hernia chest xray No grade 2 heart toxicity PATIENT CHARACTERISTICS : Age : Adult Performance status : GOG 0 1 Hematopoietic : WBC least 3,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin 1.5 mg/dL AST 3 time normal Renal : Creatinine 2.0 mg/dL Other : No second malignancy except nonmelanomatous skin cancer Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior concomitant chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior concomitant abdominal pelvic radiotherapy Surgery : No prior retroperitoneal surgery No 10 week since initial abdominal surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
	<keyword>ovarian mixed epithelial carcinoma</keyword>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cavity cancer</keyword>
</DOC>